Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients.
Intern Med J
; 46(3): 347-51, 2016 Mar.
Article
em En
| MEDLINE
| ID: mdl-26968596
ABSTRACT
There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant (ASCT). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post-transplant despite the availability of consensual guidelines.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Viroses
/
Imunização Secundária
/
Transplante de Células-Tronco Hematopoéticas
/
Profilaxia Pós-Exposição
/
Micoses
Tipo de estudo:
Etiology_studies
/
Qualitative_research
Limite:
Humans
País/Região como assunto:
Oceania
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article